TherapeuticsMD, Inc. — Director's Dealing 2022

Aug 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2022-08-18

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	Common Stock	M	2976	—	Acquired	5954	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-18	Restricted Stock Units	$0.00	M	2976	Disposed		Common Stock (2976)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	21	Indirect
Common Stock	14312	Indirect

Footnotes

F1: On August 18, 2022, the reporting person received 2,976 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022.

F2: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.

F3: The RSUs vested on July 1, 2022.